Cencora’s Lung-I Cheng: ‘Cell and gene is becoming a very competitive space’
The cell and gene therapy sector has recently seen an influx of investment and interest from the pharmaceutical industry.
Archives for April 15, 2024
Pfizer’s Velsipity UK approval to raise competition in ulcerative colitis market
Pfizer’s drug Velsipity (etrasimod), for the treatment of moderate to severe ulcerative colitis (UC), recently received approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).